Fore Biotherapeutics
A precision oncology company developing highly selective medicines for functionally & genomically defined cancer patients. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€273—409m (Dealroom.co estimates Aug 2023.)
Jerusalem Jerusalem District (HQ)
Authorizing premium user...